Norepinephrine Bitartrate Injection, Solution
Product Images NDC 0338-0128

10 FDA label images from Baxter Healthcare Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 0338-0128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram of norepinephrine bitartrate showing its molecular components and associated water of hydration.*
FDA Label Image

Representative Norepinephrene Container Label 0338-0112-20 (Image 02)

Representative Norepinephrene Container Label  0338-0112-20 (Image 02)
NOREPINEPHRINE BITARTRATE 4 mg/250 mL injection, solution in 5% dextrose for intravenous use, manufactured by Baxter Healthcare Corporation. The label includes dosage information, storage instructions, and handling precautions. The container is a VIAFLO single-dose 250 mL unit made in Ireland, with details on temperature storage and disposal.*
FDA Label Image

Representative Norepinephrene Container Label 0338-0108-20 (Image 03)

Representative Norepinephrene Container Label  0338-0108-20 (Image 03)
The label is for NORepinephrine Bitartrate in 5% Dextrose Injection, 8 mg per 250 mL solution for intravenous infusion. The label shows the text "Baxter" and indicates a 250 mL vial size. The product is manufactured by Baxter Healthcare Corporation, Deerfield, IL, made in Ireland. Storage and usage instructions are included on the label.*
FDA Label Image

Representative Norepinephrene Container Label 0338-0116-20 (Image 04)

Representative Norepinephrene Container Label  0338-0116-20 (Image 04)
Label for Norepinephrine Bitartrate in 5% Dextrose Injection, 16 mg per 250 mL (64 mcg/mL) intravenous solution. The product is for intravenous infusion only, distributed by Baxter Healthcare Corporation. The label includes storage instructions, usage warnings, and specifies single-dose use with a 30-day storage limit after opening. The package volume is 250 mL.*
FDA Label Image

0338-0040-01 Container Label.png (Image 05)

0338-0040-01 Container Label.png (Image 05)
Label for Norepinephrine Bitartrate Injection, 4 mg per 250 mL (16 mcg/mL), in 0.9% Sodium Chloride solution for intravenous infusion. The single-dose vial is manufactured by Baxter Healthcare Corporation, Deerfield, IL, and made in Ireland. The label includes warnings, storage instructions, and a barcode.*
FDA Label Image

0338-0042-01 Container Label.png (Image 06)

0338-0042-01 Container Label.png (Image 06)
Norepinephrine injection label with 8 mg/250 mL strength (32 mcg/mL) as bitartrate in 0.9% sodium chloride. The label indicates intravenous infusion use only and contains warnings about sulfites. It is manufactured by Baxter Healthcare Corporation and is presented in a Viaflo container. Storage and usage instructions are included.*
FDA Label Image

0338-0128-01 Container Label.png (Image 07)

0338-0128-01 Container Label.png (Image 07)
Norepinephrine Bitartrate injection label for a 16 mg/250 mL (64 mcg/mL) 0.9% Sodium Chloride solution. The label indicates intravenous infusion use only, with storage instructions and warnings including sulfates presence. Manufactured by Baxter Healthcare Corporation, the label includes lot, expiration info, and barcode details.*
FDA Label Image

0338-0040-01 Overwrap Label.png (Image 08)

0338-0040-01 Overwrap Label.png (Image 08)
Label for Norepinephrine Bitartrate Injection, 4 mg per 250 mL (16 mcg/mL) in 0.9% Sodium Chloride solution. It is for intravenous infusion only and labeled by Baxter Healthcare Corporation. The label includes warnings about sulfites and storage instructions, with the product made in Ireland in a Viaflo container.*
FDA Label Image

0338-0042-01 Overwrap Label.png (Image 09)

0338-0042-01 Overwrap Label.png (Image 09)
Norepinephrine Bitartrate 8 mg/250 mL intravenous injection solution label. The label indicates 0.9% sodium chloride as the vehicle, with warnings about sulfites and instructions that it is for intravenous infusion only. It is a Baxter Healthcare Corporation product, packaged in a 250 mL Viaflo container. Storage guidelines and ingredient details are included on the label.*
FDA Label Image

0338-0128-01 Overwrap Label.png (Image 10)

0338-0128-01 Overwrap Label.png (Image 10)
Label for Norepinephrine Bitartrate Injection 16 mg/250 mL (64 mcg/mL) in 0.9% Sodium Chloride, intended for intravenous infusion. The label includes warnings about sulfites, storage conditions, and usage instructions. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, made in Ireland. Features barcode, lot number, and container type information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.